Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Celsion stock price, quote, forecast and news

CLSN
US15117N5032
A2DQRG

Price

1.50
Today +/-
+0
Today %
+0 %
P

Celsion Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Celsion, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Celsion from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Celsion’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Celsion. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Celsion’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Celsion’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Celsion’s growth potential.

Celsion Revenue, EBIT and net profit per share

DateCelsion RevenueCelsion EBITCelsion Net Income
2026e74,076.3 undefined-23.37 M undefined-26.9 M undefined
2025e111,113.89 undefined-26.7 M undefined-22.62 M undefined
2024e255,000 undefined-55.49 M undefined-19.41 M undefined
2023e255,000 undefined-40.7 M undefined-30.01 M undefined
2022500,000 undefined-24.92 M undefined-35.9 M undefined
2021500,000 undefined-21.01 M undefined-20.77 M undefined
2020500,000 undefined-18.49 M undefined-21.48 M undefined
2019500,000 undefined-20.57 M undefined-16.85 M undefined
2018500,000 undefined-21.07 M undefined-11.88 M undefined
2017500,000 undefined-18.47 M undefined-20.75 M undefined
2016500,000 undefined-20.65 M undefined-22.05 M undefined
2015500,000 undefined-20.85 M undefined-22.46 M undefined
2014500,000 undefined-23.33 M undefined-25.49 M undefined
2013500,000 undefined-15.41 M undefined-8.25 M undefined
20120 undefined-22.14 M undefined-26.57 M undefined
20112 M undefined-23.02 M undefined-23.22 M undefined
20100 undefined-19.64 M undefined-18.82 M undefined
20090 undefined-17.01 M undefined-15.2 M undefined
20082.5 M undefined-11.55 M undefined-11.79 M undefined
20070 undefined-13.59 M undefined35.35 M undefined
20060 undefined-10.15 M undefined-7.58 M undefined
20050 undefined-10.37 M undefined-8.69 M undefined
20042.51 M undefined-14.6 M undefined-13.99 M undefined
20030 undefined-2.97 M undefined-2.95 M undefined

Celsion Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (k)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023e2024e2025e2026e
00000021100000000020002002000000000000000
--------50.00---------------------------------
------50.00100.00---------------------------------
0000001,0001,000000000000000000000000000000000000
-2-10000000-1-1-2-4-2-4-7-9-2-14-10-10-13-11-17-19-23-22-15-23-20-20-18-21-20-18-21-24-40-55-26-23
-------------------700.00----550.00---1,150.00---------------
-3-1-1000000-1-1-3-4-2-4-6-9-2-13-8-735-11-15-18-23-26-8-25-22-22-20-11-16-21-20-35-30-19-22-26
--66.67---------200.0033.33-50.00100.0050.0050.00-77.78550.00-38.46-12.50-600.00-131.4336.3620.0027.7813.04-69.23212.50-12.00--9.09-45.0045.4531.25-4.7675.00-14.29-36.6715.7918.18
0.010.010.010.010.020.020.020.020.020.020.040.030.040.050.060.080.090.150.170.170.170.170.160.170.20.330.550.971.321.560.120.511.171.462.135.437.140000
-----------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Celsion Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Celsion is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Celsion provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Celsion's financial health and stability.

Assets

Celsion's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Celsion must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Celsion after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Celsion's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19901991199219951996199719981999200020012002null20032004200520062007200820092010201120122013201420152016201720182019202020212022
000-1-1-3-4-2-4-6-9-13-2-13-8-735-11-15-18-23-26-8-25-22-22-20-11-16-21-20-35
00000000000000000000000001,000000000
0000000000000000000000000000-1000
0000000000000000114154-1-101-1000-1001
0000001000030000-4600115-12222505310
00000000000000000000000000000004
000000000000000000000000000100000
0000-1-1-2-2-3-6-9-9-2-13-8-7-920-13-22-22-9-21-20-18-16-7-20-15-16-23
0000000000000000-1000000000000000
000-1000000000-53-313-1-15-111-299139-10-157-308
000-1000000000-53-214-1-15-102-2910139-10-167-298
00000000000000000000000000000000
000010000000006900000404-3-4-290-500
0002002311071931200-20625210291376390723546
0001111311071931269-106252152918423610717546
00000000000000001,000000000000000000
00000000000000000000000000000000
000000017-6-1100-61-1103-519-5-96-3-681-6108-8
0000000000000000000000000-18.44-16.68-7.18-20.61-15.64-16.54-23.4
00000000000000000000000000000000

Celsion stock margins

The Celsion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Celsion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Celsion.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Celsion's sales revenue. A higher gross margin percentage indicates that the Celsion retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Celsion's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Celsion's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Celsion's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Celsion. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Celsion's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Celsion Margin History

Celsion Gross marginCelsion Profit marginCelsion EBIT marginCelsion Profit margin
2026e16.33 %-31,548.76 %-36,312.24 %
2025e16.33 %-24,031.65 %-20,358.97 %
2024e16.33 %-21,760 %-7,609.85 %
2023e16.33 %-15,960 %-11,769.71 %
202216.33 %-4,984.31 %-7,179.65 %
202116.33 %-4,201.44 %-4,153.85 %
202016.33 %-3,697.28 %-4,296.71 %
201916.33 %-4,113.09 %-3,370.31 %
201816.33 %-4,213.01 %-2,376.67 %
201716.33 %-3,693.69 %-4,149.57 %
201616.33 %-4,129.96 %-4,410.75 %
201516.33 %-4,170 %-4,492 %
201416.33 %-4,666 %-5,098 %
201316.33 %-3,082 %-1,650 %
201216.33 %0 %0 %
201116.33 %-1,151 %-1,161 %
201016.33 %0 %0 %
200916.33 %0 %0 %
200816.33 %-462 %-471.6 %
200716.33 %0 %0 %
200616.33 %0 %0 %
200516.33 %0 %0 %
200416.33 %-581.67 %-557.37 %
200316.33 %0 %0 %

Celsion Stock Sales Revenue, EBIT, Earnings per Share

The Celsion earnings per share therefore indicates how much revenue Celsion has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Celsion earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Celsion's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Celsion’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Celsion's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Celsion Revenue, EBIT and net profit per share

DateCelsion Sales per ShareCelsion EBIT per shareCelsion Earnings per Share
2026e0.01 undefined0 undefined-3.79 undefined
2025e0.02 undefined0 undefined-3.19 undefined
2024e0.04 undefined0 undefined-2.73 undefined
2023e0.04 undefined0 undefined-4.23 undefined
20220.07 undefined-3.49 undefined-5.03 undefined
20210.09 undefined-3.87 undefined-3.83 undefined
20200.23 undefined-8.68 undefined-10.08 undefined
20190.34 undefined-14.13 undefined-11.58 undefined
20180.43 undefined-17.97 undefined-10.14 undefined
20170.98 undefined-36.32 undefined-40.8 undefined
20164.04 undefined-167.06 undefined-178.41 undefined
20150.32 undefined-13.37 undefined-14.4 undefined
20140.38 undefined-17.67 undefined-19.31 undefined
20130.52 undefined-15.89 undefined-8.51 undefined
20120 undefined-40.25 undefined-48.31 undefined
20116.06 undefined-69.76 undefined-70.36 undefined
20100 undefined-98.2 undefined-94.1 undefined
20090 undefined-100.06 undefined-89.41 undefined
200815.63 undefined-72.19 undefined-73.69 undefined
20070 undefined-79.94 undefined207.94 undefined
20060 undefined-59.71 undefined-44.59 undefined
20050 undefined-61 undefined-51.12 undefined
200414.76 undefined-85.88 undefined-82.29 undefined
20030 undefined-19.8 undefined-19.67 undefined

Celsion business model

Celsion Corp is a publicly traded company founded in 1982 and headquartered in Lawrenceville, New Jersey. The company was established to develop innovative solutions for cancer treatment. Celsion Corp is divided into various business areas. The largest area is research and development of cancer therapies. The company strives to utilize the latest technologies and treatment options to combat cancer. The research areas of Celsion Corp are ThermoDox, GEN-1, and UltraPorin. ThermoDox is the most advanced product of Celsion Corp. It is a treatment method that uses the chemotherapy drug Oxaliplatin in combination with heat to destroy tumor cells. The company has successfully completed clinical trials and is working to obtain market approval for ThermoDox. Another research area of Celsion is GEN-1. It is an immunotherapeutic treatment used to enhance the immune response against cancer cells. Again, the company has successfully completed clinical trials and is working towards market approval. In addition, Celsion Corp is working on the development of UltraPorin. This is a technology aimed at improving the effectiveness of chemotherapy drugs by increasing the drugs' access to tumor cells. Celsion Corp has strong partnerships with leading companies in the industry, such as the National Cancer Institute, Duke University, and Zhejiang Hisun Pharmaceutical. The company is committed to making its technologies available worldwide. The business model of Celsion Corp is to develop innovative solutions for cancer treatment, conduct clinical trials to evaluate the safety and efficacy of the products, and obtain market approval. The company works closely with doctors and hospitals to ensure its products are available to patients. The company has earned a reputation as an innovation leader in the industry. Celsion Corp has received numerous awards and recognitions for its groundbreaking technologies and products. Overall, Celsion Corp has a promising future in the field of cancer treatment. The company is dedicated to continuously developing innovative technologies and products to advance the fight against cancer. Celsion is one of the most popular companies on Eulerpool.com.

Celsion SWOT Analysis

Strengths

Celsion Corp has a strong portfolio of innovative products and technologies that differentiate it from competitors. The company's expertise in developing advanced drug delivery systems gives it a competitive advantage in the pharmaceutical industry.

Celsion Corp has established strategic partnerships and collaborations with renowned research institutions, enabling access to leading research and development capabilities and resources. This network provides an opportunity for knowledge sharing and enhances the company's potential for breakthrough discoveries.

Weaknesses

Celsion Corp faces challenges in terms of limited financial resources, which may restrict its ability to scale up operations and invest in new projects. This constraint could hinder the company's growth and expansion opportunities, particularly when competing against well-funded industry players.

The company has a relatively small customer base and limited market penetration. This could be attributed to the competitive nature of the pharmaceutical industry and the time-consuming process of gaining regulatory approvals.

Opportunities

Celsion Corp has the opportunity to expand its market presence by investing in research and development to develop new products and therapies. The increasing focus on personalized medicine and targeted treatments opens avenues for the company to address unmet medical needs and capture a larger market share.

The growing prevalence of diseases, such as cancer, provides a significant market opportunity for Celsion Corp. The company can leverage its expertise in drug delivery systems to offer innovative treatments and improve patient outcomes.

Threats

Celsion Corp operates in a heavily regulated industry, making it susceptible to changes in government regulations and policies. Compliance with these regulations can be time-consuming and costly, potentially impacting the company's profitability and ability to bring products to market.

Intense competition within the pharmaceutical industry poses a threat to Celsion Corp. Larger, well-established pharmaceutical companies have significant resources, established distribution networks, and greater brand recognition, which may hinder Celsion Corp's ability to gain market share.

Celsion historical P/E ratio, EBIT, and P/S ratio.

Celsion shares outstanding

The number of shares was Celsion in 2023 — This indicates how many shares 7.143 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Celsion earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Celsion's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Celsion’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Celsion's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Celsion Stock splits

In Celsion's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Celsion.

Celsion list of shareholders

%
Name
Stocks
Change
Date
3.31 % The Vanguard Group, Inc.234,953-24,1473/31/2022
2.58 % FiveT Capital AG183,333183,3331/22/2021
1.06 % Two Sigma Investments, LP75,25725,6033/31/2022
1.04 % BlackRock Institutional Trust Company, N.A.73,7227493/31/2022
0.75 % Le (Goff Corinne)53,00053,0007/18/2022
0.71 % Geode Capital Management, L.L.C.50,457-23/31/2022
0.46 % Citadel Advisors LLC32,90030,6373/31/2022
0.37 % Renaissance Technologies LLC26,55519,3123/31/2022
0.29 % Tardugno (Michael H)20,5134,0004/12/2022
0.24 % Fritz (Frederick J)16,7665,0004/8/2022
1
2
3
4
5
...
9

Celsion Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Zhejiang Hisun Pharm A Stock
Zhejiang Hisun Pharm A
SupplierCustomer0,200,810,72--0,03-
1

Most common questions regarding Celsion

What values and corporate philosophy does Celsion represent?

Celsion Corp represents innovation, dedication, and a commitment to improving patient outcomes. With a focus on developing transformative oncology therapies, the company aims to revolutionize cancer treatment. Celsion's corporate philosophy revolves around collaboration, scientific excellence, and patient-centricity. By leveraging its extensive expertise and advanced technologies, Celsion Corp strives to deliver cutting-edge solutions that address unmet medical needs. With a strong emphasis on research and development, the company continuously seeks breakthroughs in cancer therapies to provide hope and improve the lives of those affected by this devastating disease.

In which countries and regions is Celsion primarily present?

Celsion Corp is primarily present in the United States of America.

What significant milestones has the company Celsion achieved?

Celsion Corp has achieved significant milestones in its journey. The company successfully developed ThermoDox, a novel drug candidate for localized heat-activated chemotherapy. Celsion Corp received Fast Track Designation from the U.S. FDA for ThermoDox and completed Phase III clinical trials, demonstrating promising results in patients with hepatocellular carcinoma. Furthermore, the company successfully presented positive data at renowned medical conferences, gaining recognition for its innovative technology. Celsion Corp's milestones highlight its dedication to advancing cancer treatments and its commitment to improving patient outcomes.

What is the history and background of the company Celsion?

Celsion Corp is a pharmaceutical company established in 1982 and headquartered in Lawrenceville, New Jersey. The company focuses on the development of innovative oncology treatments. Throughout its history, Celsion Corp has conducted extensive research and amassed substantial expertise in the field of heat-activated therapies for cancer treatment. They have a strong commitment to improving patient outcomes and revolutionizing cancer therapies. With a diverse pipeline of promising drug candidates and strategic partnerships, Celsion Corp continues to strive towards breakthrough advancements in oncology.

Who are the main competitors of Celsion in the market?

The main competitors of Celsion Corp in the market include companies such as Biovaxys Technology Corp, KD Pharma Group, NewLink Genetics Corporation, and Therma Bright Inc. These companies operate in the same sector as Celsion Corp and offer similar products and services. However, Celsion Corp distinguishes itself through its innovative approach, extensive research and development efforts, and strategic partnerships. By continuously striving for advancements in the field, Celsion Corp remains competitive in the market and aims to provide unique solutions that cater to the needs of patients and healthcare providers.

In which industries is Celsion primarily active?

Celsion Corp is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Celsion?

The business model of Celsion Corp is focused on developing and commercializing innovative oncology treatments. The company primarily specializes in heat-activated drug delivery systems and utilizes its proprietary technology, ThermoDox®, to target and deliver chemotherapeutic agents directly to tumors. By using localized heat via radiofrequency ablation or high-intensity focused ultrasound, ThermoDox® enables targeted drug release and enhances the effectiveness of chemotherapy while minimizing side effects. Through strategic collaborations and clinical trials, Celsion Corp aims to provide effective and safer treatment options for patients fighting various forms of cancer.

What is the P/E ratio of Celsion 2024?

The Celsion P/E ratio is -0.55.

What is the P/S ratio of Celsion 2024?

The Celsion P/S ratio is 42.13.

What is the AlleAktien quality score of Celsion?

The AlleAktien quality score for Celsion is 3/10.

What is the revenue of Celsion 2024?

The expected Celsion revenue is 255,000 USD.

How high is the profit of Celsion 2024?

The expected Celsion profit is -19.41 M USD.

What is the business model of Celsion

Celsion Corp is a biotechnology company specialized in the development and commercialization of cancer treatments. The company focuses on providing state-of-the-art therapies aimed at treating malignant tumors and improving the lives of cancer patients. Celsion operates through a versatile business model, offering a range of products and services. The company has an advanced research and development team dedicated to developing new treatment approaches. One of these product approaches is the so-called ThermoDox®, which inhibits the growth of cancer cells due to temperature changes. Celsion also collaborates closely with research institutions and clinics to test its solutions on cancer patients. This collaboration allows the company to receive feedback from professionals and patients, and improve the effectiveness of its therapies. Another important segment of the company is providing services to other companies, such as support in the research and development of new therapy concepts. The company also offers manufacturing and marketing of drugs and other cancer prevention treatments. Celsion's research and development efforts are focused on the use of nanotechnology, aiming to target cancer cells with new therapy concepts. This research field is highly promising and further advancements are expected in the future. Celsion has tailored its business model to the needs of cancer patients and the industry, aiming to improve the lives of people and clinical outcomes in this field. The company aims to work as a long-term partner for clinics and other companies, and collaboration and provision of products and services in this field also increase the company's growth potential. In conclusion, Celsion Corp is a biotechnology company with a versatile business model that offers therapies and services for cancer patients. The company works in the field of cancer research and development to offer innovative treatment approaches. Additionally, Celsion also provides services to other companies to support the manufacturing and marketing of drugs in the field of cancer prevention. Through collaboration of research, development, and production, the potential in this field is further realized.

What is the Celsion dividend?

Celsion pays a dividend of 0 USD distributed over payouts per year.

How often does Celsion pay dividends?

The dividend cannot currently be calculated for Celsion or the company does not pay out a dividend.

What is the Celsion ISIN?

The ISIN of Celsion is US15117N5032.

What is the Celsion WKN?

The WKN of Celsion is A2DQRG.

What is the Celsion ticker?

The ticker of Celsion is CLSN.

How much dividend does Celsion pay?

Over the past 12 months, Celsion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Celsion is expected to pay a dividend of 0 USD.

What is the dividend yield of Celsion?

The current dividend yield of Celsion is .

When does Celsion pay dividends?

Celsion pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Celsion?

Celsion paid dividends every year for the past 0 years.

What is the dividend of Celsion?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Celsion located?

Celsion is assigned to the 'Health' sector.

Wann musste ich die Aktien von Celsion kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Celsion from 7/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.

When did Celsion pay the last dividend?

The last dividend was paid out on 7/22/2024.

What was the dividend of Celsion in the year 2023?

In the year 2023, Celsion distributed 0 USD as dividends.

In which currency does Celsion pay out the dividend?

The dividends of Celsion are distributed in USD.

All fundamentals about Celsion

Our stock analysis for Celsion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celsion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.